HMC CAPITAL LIMITED (HMC)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

HMC

HMC - HMC CAPITAL LIMITED

FNArena Sector : Wealth Management & Investments
Year End: June
GICS Industry Group : Real Estate
Debt/EBITDA: 9.1
Index: ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.53

16 Apr
2025

-0.090

OPEN

$4.56

-1.95%

HIGH

$4.63

2,429,599

LOW

$4.52

TARGET
$8.47 87.0% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AEF . AMP . ASX . AVC . BVS . CGF . CVW . DJW . ENN . GDC . GDG . GQG . HUB . IFL . IFT . IRE . KAM . KSL . MAF . MFG . MQG . NGI . NWL . PAC . PNI . PPS . PPT . PTM . QAL . RPL . RZI . WHF .
FNARENA'S MARKET CONSENSUS FORECASTS
HMC: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 18.9 50.8 xxx
DPS (cps) xxx 12.0 12.0 xxx
EPS Growth xxx - 3.0% 100.0% xxx
DPS Growth xxx 0.0% 0.0% xxx
PE Ratio xxx N/A 8.9 xxx
Dividend Yield xxx N/A 2.7% xxx
Div Pay Ratio(%) xxx 63.6% 23.6% xxx

Dividend yield today if purchased 3 years ago: 1.62%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 2.66

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 27/08 - ex-div 6c (franking 70%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 20202021202220232024
EPS Basic xxxxxxxxxxxx18.9
DPS All xxxxxxxxxxxx12.0
Sales/Revenue xxxxxxxxxxxx81.4 M
Book Value Per Share xxxxxxxxxxxx328.0
Net Operating Cash Flow xxxxxxxxxxxx69.6 M
Net Profit Margin xxxxxxxxxxxx81.08 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 20202021202220232024
Return on Capital Employed xxxxxxxxxxxx5.85 %
Return on Invested Capital xxxxxxxxxxxx5.84 %
Return on Assets xxxxxxxxxxxx4.21 %
Return on Equity xxxxxxxxxxxx5.85 %
Return on Total Capital xxxxxxxxxxxx1.34 %
Free Cash Flow ex dividends xxxxxxxxxxxx27.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 20202021202220232024
Short-Term Debt xxxxxxxxxxxx200 M
Long Term Debt xxxxxxxxxxxx2 M
Total Debt xxxxxxxxxxxx202 M
Goodwill - Gross xxxxxxxxxxxx49 M
Cash & Equivalents - Generic xxxxxxxxxxxx255 M
Price To Book Value xxxxxxxxxxxx2.20

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 20202021202220232024
Capex xxxxxxxxxxxx0.0 M
Capex % of Sales xxxxxxxxxxxx0.00 %
Cost of Goods Sold xxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxx59 M
Research & Development xxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxx733 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

21/03/2025

1

Buy

$12.40

173.73%

UBS notes results for office REITs improved in the February reporting season and leasing spreads could improve as lower post-Covid leases are replaced, assuming typical 5-year lease terms. 

The broker believes Australian REITs are looking more supportive vs the local market and in a global context.

In the broker's recent meeting with investors, HMC Capital was discussed in the context of fund manager momentum and risks.

Buy rating and $12.40 target price.

FORECAST
UBS forecasts a full year FY25 dividend of 12.00 cents and EPS of 61.00 cents.
UBS forecasts a full year FY26 dividend of 12.70 cents and EPS of 34.20 cents.

Macquarie

xx/xx/xxxx

-1

xx xxxxxx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxxxxx xx xxxx xxxx xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Goldman Sachs

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

13/03/2025

2

Upgrade to Overweight from Underweight

$8.65

90.95%

Jarden upgraded the rating on HMC Capital to Overweight from Underweight following the significant share price fall over the last three months.

The broker acknowledges ongoing challenges remain with its listed funds - HealthCo Healthcare & Wellness REIT ((HCW)) and Digico Infrastructure Reit Stapled Unit ((DGT)) but the price decline is still overdone.

The broker cut the target price to $8.65 from $9.95 to account for the risks in the uncertain macro environment but highlights a 17.5% upside risk if its 19% compounded growth for underlying EPS (FY25-28) comes to pass.

FORECAST
Jarden forecasts a full year FY25 dividend of 12.00 cents and EPS of 28.90 cents.
Jarden forecasts a full year FY26 dividend of 12.00 cents and EPS of 33.10 cents.
Access Extra Coverage Research History >

HMC STOCK CHART

FNArena News on HMC

1
Australian Broker Call *Extra* Edition – Apr 07, 2025

Apr 07 2025 - Daily Market Reports
2
Next Week At A Glance – 7-11 Apr 2025

Apr 04 2025 - Weekly Reports
3
Rudi’s View: Time For Appreciating Quality

Apr 02 2025 - Rudi's View
4
Next Week At A Glance 24-28 Mar 2025

Mar 21 2025 - Weekly Reports
5
Next Week At A Glance – 17-21 Mar 2025

Mar 14 2025 - Weekly Reports

Latest Wealth Management & Investments News

1
In Brief: Greatland Gold, Pinnacle, ResMed & Hub24

10:30 AM - Weekly Reports
2
Weekly Update On LICs & LITs – 15-Apr-2025

Apr 15 2025 - Weekly Reports
3
Has Netwealth Been Punished Enough?

Apr 15 2025 - Australia
4
Weekly Update On LICs & LITs – 08-Apr-2025

Apr 08 2025 - Weekly Reports
5
Monthly Listed Investment Trust Report – Apr 2025

Apr 07 2025 - Australia
6
Macquarie Shares Poised For Sharp Bounce

Apr 01 2025 - Technicals
7
Weekly Update On LICs & LITs – 25-Mar-2025

Mar 25 2025 - Weekly Reports
8
Weekly Update On LICs & LITs – 18-Mar-2025

Mar 18 2025 - Weekly Reports
9
Confident Qualitas Overlooked By Equity Investors

Mar 17 2025 - Small Caps
10
Future Looks Bright For Generation Development

Mar 11 2025 - Small Caps